Please use this identifier to cite or link to this item:
https://doi.org/10.1186/s13287-018-0796-2
DC Field | Value | |
---|---|---|
dc.title | Amenable epigenetic traits of dental pulp stem cells underlie high capability of xeno-free episomal reprogramming | |
dc.contributor.author | Thekkeparambil Chandrabose, S | |
dc.contributor.author | Sriram, S | |
dc.contributor.author | Subramanian, S | |
dc.contributor.author | Cheng, S | |
dc.contributor.author | Ong, W.K | |
dc.contributor.author | Rozen, S | |
dc.contributor.author | Kasim, N.H.A | |
dc.contributor.author | Sugii, S | |
dc.date.accessioned | 2020-10-20T05:05:32Z | |
dc.date.available | 2020-10-20T05:05:32Z | |
dc.date.issued | 2018 | |
dc.identifier.citation | Thekkeparambil Chandrabose, S, Sriram, S, Subramanian, S, Cheng, S, Ong, W.K, Rozen, S, Kasim, N.H.A, Sugii, S (2018). Amenable epigenetic traits of dental pulp stem cells underlie high capability of xeno-free episomal reprogramming. Stem Cell Research and Therapy 9 (1) : 68. ScholarBank@NUS Repository. https://doi.org/10.1186/s13287-018-0796-2 | |
dc.identifier.issn | 17576512 | |
dc.identifier.uri | https://scholarbank.nus.edu.sg/handle/10635/178098 | |
dc.description.abstract | Background: While a shift towards non-viral and animal component-free methods of generating induced pluripotent stem (iPS) cells is preferred for safer clinical applications, there is still a shortage of reliable cell sources and protocols for efficient reprogramming. Methods: Here, we show a robust episomal and xeno-free reprogramming strategy for human iPS generation from dental pulp stem cells (DPSCs) which renders good efficiency (0.19%) over a short time frame (13-18 days). Results: The robustness of DPSCs as starting cells for iPS induction is found due to their exceptional inherent stemness properties, developmental origin from neural crest cells, specification for tissue commitment, and differentiation capability. To investigate the epigenetic basis for the high reprogramming efficiency of DPSCs, we performed genome-wide DNA methylation analysis and found that the epigenetic signature of DPSCs associated with pluripotent, developmental, and ecto-mesenchymal genes is relatively close to that of iPS and embryonic stem (ES) cells. Among these genes, it is found that overexpression of PAX9 and knockdown of HERV-FRD improved the efficiencies of iPS generation. Conclusion: In conclusion, our study provides underlying epigenetic mechanisms that establish a robust platform for efficient generation of iPS cells from DPSCs, facilitating industrial and clinical use of iPS technology for therapeutic needs. © 2018 The Author(s). | |
dc.rights | Attribution 4.0 International | |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ | |
dc.source | Unpaywall 20201031 | |
dc.subject | Article | |
dc.subject | cell differentiation | |
dc.subject | cell line | |
dc.subject | cell maturation | |
dc.subject | controlled study | |
dc.subject | dental pulp stem cell | |
dc.subject | DNA methylation | |
dc.subject | embryonic stem cell | |
dc.subject | epigenetics | |
dc.subject | gene | |
dc.subject | gene expression | |
dc.subject | gene knockdown | |
dc.subject | genetic trait | |
dc.subject | genome-wide association study | |
dc.subject | HERV FRD gene | |
dc.subject | human | |
dc.subject | human cell | |
dc.subject | induced pluripotent stem cell | |
dc.subject | neural crest cell | |
dc.subject | nuclear reprogramming | |
dc.subject | PAX9 gene | |
dc.subject | priority journal | |
dc.subject | animal | |
dc.subject | cell culture | |
dc.subject | cell reprogramming technique | |
dc.subject | cytology | |
dc.subject | genetic epigenesis | |
dc.subject | genetics | |
dc.subject | mesenchymal stem cell | |
dc.subject | metabolism | |
dc.subject | mouse | |
dc.subject | nonobese diabetic mouse | |
dc.subject | plasmid | |
dc.subject | primary cell culture | |
dc.subject | procedures | |
dc.subject | SCID mouse | |
dc.subject | tooth pulp | |
dc.subject | Animals | |
dc.subject | Cells, Cultured | |
dc.subject | Cellular Reprogramming | |
dc.subject | Cellular Reprogramming Techniques | |
dc.subject | Dental Pulp | |
dc.subject | Epigenesis, Genetic | |
dc.subject | Humans | |
dc.subject | Mesenchymal Stem Cells | |
dc.subject | Mice | |
dc.subject | Mice, Inbred NOD | |
dc.subject | Mice, SCID | |
dc.subject | Plasmids | |
dc.subject | Primary Cell Culture | |
dc.type | Article | |
dc.contributor.department | DUKE-NUS MEDICAL SCHOOL | |
dc.description.doi | 10.1186/s13287-018-0796-2 | |
dc.description.sourcetitle | Stem Cell Research and Therapy | |
dc.description.volume | 9 | |
dc.description.issue | 1 | |
dc.description.page | 68 | |
Appears in Collections: | Staff Publications Elements |
Show simple item record
Files in This Item:
File | Description | Size | Format | Access Settings | Version | |
---|---|---|---|---|---|---|
10_1186_s13287-018-0796-2.pdf | 1.56 MB | Adobe PDF | OPEN | None | View/Download |
This item is licensed under a Creative Commons License